Artgen Biotech PJSC Statistics
Total Valuation
MOEX:ISKJ has a market cap or net worth of RUB 4.29 billion. The enterprise value is 4.94 billion.
| Market Cap | 4.29B |
| Enterprise Value | 4.94B |
Important Dates
The next estimated earnings date is Friday, May 15, 2026.
| Earnings Date | May 15, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MOEX:ISKJ has 71.99 million shares outstanding. The number of shares has increased by 1.06% in one year.
| Current Share Class | 71.99M |
| Shares Outstanding | 71.99M |
| Shares Change (YoY) | +1.06% |
| Shares Change (QoQ) | -32.53% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 46.16.
| PE Ratio | 46.16 |
| Forward PE | n/a |
| PS Ratio | 2.50 |
| PB Ratio | 3.76 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 210.58 |
| P/OCF Ratio | 22.47 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 19.50, with an EV/FCF ratio of 242.47.
| EV / Earnings | 50.91 |
| EV / Sales | 2.88 |
| EV / EBITDA | 19.50 |
| EV / EBIT | 44.48 |
| EV / FCF | 242.47 |
Financial Position
The company has a current ratio of 1.79, with a Debt / Equity ratio of 0.85.
| Current Ratio | 1.79 |
| Quick Ratio | 0.94 |
| Debt / Equity | 0.85 |
| Debt / EBITDA | 3.46 |
| Debt / FCF | 47.41 |
| Interest Coverage | 1.53 |
Financial Efficiency
Return on equity (ROE) is 9.72% and return on invested capital (ROIC) is 8.89%.
| Return on Equity (ROE) | 9.72% |
| Return on Assets (ROA) | 3.02% |
| Return on Invested Capital (ROIC) | 8.89% |
| Return on Capital Employed (ROCE) | 6.19% |
| Weighted Average Cost of Capital (WACC) | 4.97% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.61 |
| Inventory Turnover | 7.44 |
Taxes
| Income Tax | -22.20M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +55.78% in the last 52 weeks. The beta is 0.03, so MOEX:ISKJ's price volatility has been lower than the market average.
| Beta (5Y) | 0.03 |
| 52-Week Price Change | +55.78% |
| 50-Day Moving Average | 66.85 |
| 200-Day Moving Average | 91.44 |
| Relative Strength Index (RSI) | 40.78 |
| Average Volume (20 Days) | 234,009 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, MOEX:ISKJ had revenue of RUB 1.72 billion and earned 96.95 million in profits. Earnings per share was 1.29.
| Revenue | 1.72B |
| Gross Profit | 136.94M |
| Operating Income | 136.94M |
| Pretax Income | 85.48M |
| Net Income | 96.95M |
| EBITDA | 279.02M |
| EBIT | 136.94M |
| Earnings Per Share (EPS) | 1.29 |
Balance Sheet
The company has 565.37 million in cash and 964.99 million in debt, with a net cash position of -399.62 million or -5.55 per share.
| Cash & Cash Equivalents | 565.37M |
| Total Debt | 964.99M |
| Net Cash | -399.62M |
| Net Cash Per Share | -5.55 |
| Equity (Book Value) | 1.14B |
| Book Value Per Share | 6.40 |
| Working Capital | 613.93M |
Cash Flow
In the last 12 months, operating cash flow was 190.75 million and capital expenditures -170.39 million, giving a free cash flow of 20.36 million.
| Operating Cash Flow | 190.75M |
| Capital Expenditures | -170.39M |
| Depreciation & Amortization | 142.08M |
| Net Borrowing | 229.60M |
| Free Cash Flow | 20.36M |
| FCF Per Share | 0.28 |
Margins
Gross margin is 7.98%, with operating and profit margins of 7.98% and 5.65%.
| Gross Margin | 7.98% |
| Operating Margin | 7.98% |
| Pretax Margin | 4.98% |
| Profit Margin | 5.65% |
| EBITDA Margin | 16.26% |
| EBIT Margin | 7.98% |
| FCF Margin | 1.19% |
Dividends & Yields
MOEX:ISKJ does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 57.97% |
| Buyback Yield | -1.06% |
| Shareholder Yield | -1.06% |
| Earnings Yield | 2.26% |
| FCF Yield | 0.47% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |